A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Clinical trials in Dalton, GA: what is studied
Cancer. Cancer studies in Dalton run mainly through Tennessee Oncology's Dalton office and the Peeples Cancer Institute at Hamilton Medical Center, and often cover cancers such as lung cancer and kidney cancer; see our oncology clinical trials page.
Kidney, liver, and metabolic conditions. Local practices and research sites also take part in studies for chronic kidney disease, fatty liver disease, obesity, and type 2 diabetes. Our guide explains what works for fatty liver, and our weight loss clinical trials page lists studies of new weight loss medicines.
Paid clinical trials in Dalton
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything. Any payment has to be approved by the institutional review board that oversees the study, and FDA guidance says it should accrue as the study goes on rather than depend on finishing it. Many studies at least cover travel, which can make a study in Chattanooga or Atlanta more practical. Our guide explains how much clinical trials pay and how payment is decided.
Clinical trials near Dalton: Chattanooga and Atlanta
Dalton has a small number of studies of its own, but Chattanooga, about 30 miles away, has many more, and Atlanta is about 90 miles south. This page lists studies in Georgia, so studies across the state line appear on our Chattanooga page instead. Studies across the state are on our Georgia clinical trials page.
Can I join a clinical trial in Chattanooga if I live in Dalton?
Usually yes. Most studies accept anyone who meets the criteria and can attend the visits, wherever they live, so the main question is how often you would need to make the trip. The study coordinator can tell you the visit schedule and whether travel costs are covered.
How to join a clinical trial in Dalton
- Identify your trial. Use the filters on this page to narrow the list by condition or phase, or search a diagnosis such as fatty liver disease or lung cancer.
- Check the location. Each study lists the sites where it recruits, so confirm it has a site in Dalton, or decide whether a site in Chattanooga or Atlanta would work for you.
- Explore study details. Read the eligibility criteria and, where listed, the number of visits and how long the study lasts before applying.
- Complete the health profile. Click "See if you qualify" to begin the 5-step application. Have ready your diagnosis and when it was made, the medicines you take, and any recent test results.
- Submit the application. A clinical trial coordinator reviews it and contacts you to discuss next steps. Nothing is decided until informed consent, and participation is voluntary at every step.
Our guide to finding clinical trials near you covers each step in more detail.
Do I need health insurance to join a clinical trial?
Not necessarily. Study related care, including the study medicine and the visits and tests the protocol requires, is typically provided at no cost to participants, and the team explains anything that would be billed to insurance before you agree.
Our guide Are Clinical Trials Free? explains costs, insurance, and compensation.